ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO105

Urinary Waxy Casts Are Associated with Greater Severity of Acute Tubular Injury

Session Information

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Authors

  • Rivera, Maria Soledad, The University of Queensland, New Orleans, Louisiana, United States
  • Velez, Juan Carlos Q., The University of Queensland, New Orleans, Louisiana, United States
Background

Waxy casts (WxCs) constitute a recognized finding during microscopic examination of the urinary sediment (MicrExUrSed) and they are classically linked to chronic kidney disease (CKD). It is less clear whether WxCs are a relevant finding in acute kidney injury (AKI). We hypothesized that identification of WxCs in AKI due to acute tubular injury (ATI) provides prognostic information.

Methods

We conducted a prospective observational study in patients seen in the inpatient nephrology consultation team with AKI stage ≥ 1 (AKIN) over a 1.5-yr period. On the day of the consult, MicrExUrSed was performed to determine the percentage of low power fields (lpf) with WxCs and to assess a validated score for ATI based on granular casts and tubular epithelial cells per lpf [Perazella score (PS): score ≥ 2 consistent with ATI]. The primary outcome measure was need for dialysis at 30 days (RRT).

Results

Urine specimens from 167 patients [median age 58 (25 – 88), 43% women] were assessed. The etiology of AKI (pure de novo AKI 56%, AKI on CKD 44%) was ischemic ATI (41%), toxic ATI (14%), ischemic/toxic ATI (17%) and others (28%). WxCs were found in 47 patients (28%), 33 (70%) of which had pure de novo AKI. Median serum creatinine for those with WxCs was 3.7 (2.8 – 4.9) mg/dL compared to 3.1 (2.4 – 4.6) mg/dL for those without WxCs (p = 0.087). Having >10% lpf w/ ≥1 WxCs was associated with greater risk for RRT [relative risk (RR): 2.3, CI 1.4 – 3.5, p = 0.0003). As reported by others, PS ≥ 2 was associated with increased risk for RRT (RR: 2.6, CI 1.1 - 6.6, p = 0.04). When presence of WxCs was added to a PS ≥ 2, the RR for need for RRT became stronger (RR: 6.0, CI 2.9 - 12.5, p< 0.0001). In addition, the greater the abundance of WxCs, the greater the need for RRT: need for RRT was 26% (31/120), 43% (20/47), 59% (13/22), and 60% (6/10) for those with none, >0%, >10% and ≥50% lpf w/ ≥1 WxCs, respectively (p = 0.0003 for chi-square for trend).

Conclusion

WxCs can be found in a significant proportion of patients with AKI, even among those without preexisting CKD. Among patients with ATI, the presence and abundance of WxCs are associated with a greater risk for need for RRT, suggesting that WxCs carry similar and potentially additive prognostic value to that of granular casts.